Trademark: 87211780
Status Date
Tuesday, October 16, 2018
Registration Number
5583284
Registration Date
Tuesday, October 16, 2018
Filing Date
Friday, October 21, 2016
Published for Opposition
Tuesday, June 5, 2018
5 Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals for the treatment of genetic or cell based conditions; small molecules, vaccines, biologics, enzymes and enzyme preparations all for medical purposes in connection with gene therapy for the treatment of genetic or cell based conditions; pharmaceuticals for medical purposes for the delivery of genes to cells for the treatment of genetic or cell based conditions; viral, retroviral and non-viral vectors, all for medical purposes in gene therapy, namely, for the treatment of genetic or cell based conditions; biochemical and chemical preparations for medical purposes in gene therapy, namely, for the treatment of genetic or cell based conditions
1 Chemicals for use in industry and science; enzymes for scientific and research purposes; biochemicals, namely, precursors for in vitro genetic engineering use; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; micro-organisms for laboratory and scientific research use, viruses for laboratory and scientific research use, cell cultures for laboratory and scientific research use, plasmids and cultures of micro-organisms for laboratory and scientific research use, nucleic acid sequences for laboratory and scientific research use, cloning vehicles in the nature of plasmids, microbes and chemical reagents for DNA cloning for laboratory and scientific research use, chemicals for laboratory and scientific research and development use in biotechnology research and development and recombinant nucleic acid variations thereof for laboratory and scientific research use, all of the foregoing for in-vivo use; biochemical preparations for manufacture of viral, retroviral and non-viral vectors for medical research and pharmaceutical research and development; biochemical preparations for the manufacture of viral, retroviral and non-viral vectors, all for medical purposes in gene therapy, namely for the prevention of genetic or cell-based conditions
Oct 16, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 16, 2018
Registered-Principal Register
Sep 7, 2018
1(B) Basis Deleted; Proceed To Registration
Aug 7, 2018
Notice Of Allowance Cancelled
Sep 7, 2018
Case Assigned To Intent To Use Paralegal
Aug 7, 2018
Teas Delete 1(B) Basis Received
Jul 31, 2018
Noa E-Mailed - Sou Required From Applicant
Jun 8, 2018
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 8, 2018
Teas Change Of Owner Address Received
Jun 5, 2018
Official Gazette Publication Confirmation E-Mailed
Jun 5, 2018
Published For Opposition
May 16, 2018
Notification Of Notice Of Publication E-Mailed
May 3, 2018
Approved For Pub - Principal Register
May 1, 2018
Examiner's Amendment Entered
May 1, 2018
Notification Of Examiners Amendment E-Mailed
May 1, 2018
Examiners Amendment E-Mailed
May 1, 2018
Examiners Amendment -Written
Apr 11, 2018
Examiner's Amendment Entered
Apr 11, 2018
Notification Of Examiners Amendment E-Mailed
Apr 11, 2018
Examiners Amendment E-Mailed
Apr 11, 2018
Examiners Amendment -Written
Mar 22, 2018
Teas/Email Correspondence Entered
Mar 22, 2018
Correspondence Received In Law Office
Mar 22, 2018
Teas Response To Office Action Received
Sep 22, 2017
Notification Of Non-Final Action E-Mailed
Sep 22, 2017
Non-Final Action E-Mailed
Sep 22, 2017
Non-Final Action Written
Aug 29, 2017
Teas/Email Correspondence Entered
Aug 29, 2017
Correspondence Received In Law Office
Aug 23, 2017
Assigned To Lie
Aug 1, 2017
Teas Response To Office Action Received
Feb 2, 2017
Notification Of Non-Final Action E-Mailed
Feb 2, 2017
Non-Final Action E-Mailed
Feb 2, 2017
Non-Final Action Written
Jan 31, 2017
Assigned To Examiner
Oct 27, 2016
New Application Office Supplied Data Entered
Oct 25, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
